Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre O Chappuis

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|October 3, 2002
Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor statusWilliam D Foulkes, John Goffin, Jean-Sébastien Brunet, et al.
British Journal of Cancer|June 23, 2020
Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendationsChang Ming, Valeria Viassolo, Nicole Probst-Hensch, et al.
International Journal of Cancer|November 2, 2007
Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based studyHelena M Verkooijen, Gerald Fioretta, Elisabetta Rapiti, et al.
Breast Cancer Research and Treatment|February 13, 2014
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based studyAurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, et al.
Cancer Medicine|February 18, 2017
Opportunities for improving triple-negative breast cancer outcomes: results of a population-based studyElisabetta Rapiti, Kim Pinaud, Pierre O Chappuis, et al.
International Journal of Cancer|July 21, 2009
Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriersAnnick Wong Wong Keet, Munir Al-Rafae, Pierre O Chappuis, et al.
Plos One|October 8, 2020
Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?Marta Fadda, Pierre O Chappuis, Maria C Katapodi, et al.
Breast Cancer Research and Treatment|December 23, 2006
Survival after bilateral breast cancer: results from a population-based studyHelena M Verkooijen, Vanessa Chatelain, Gérald Fioretta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2006
Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosisElisabetta Rapiti, Helena M Verkooijen, Georges Vlastos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 16, 2014
Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutationsMaria Caiata-Zufferey, Olivia Pagani, Viviane Cina, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|October 3, 2002
Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor statusWilliam D Foulkes, John Goffin, Jean-Sébastien Brunet, et al.
British Journal of Cancer|June 23, 2020
Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendationsChang Ming, Valeria Viassolo, Nicole Probst-Hensch, et al.
International Journal of Cancer|November 2, 2007
Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based studyHelena M Verkooijen, Gerald Fioretta, Elisabetta Rapiti, et al.
Breast Cancer Research and Treatment|February 13, 2014
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based studyAurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, et al.
Cancer Medicine|February 18, 2017
Opportunities for improving triple-negative breast cancer outcomes: results of a population-based studyElisabetta Rapiti, Kim Pinaud, Pierre O Chappuis, et al.
International Journal of Cancer|July 21, 2009
Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriersAnnick Wong Wong Keet, Munir Al-Rafae, Pierre O Chappuis, et al.
Plos One|October 8, 2020
Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?Marta Fadda, Pierre O Chappuis, Maria C Katapodi, et al.
Breast Cancer Research and Treatment|December 23, 2006
Survival after bilateral breast cancer: results from a population-based studyHelena M Verkooijen, Vanessa Chatelain, Gérald Fioretta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2006
Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosisElisabetta Rapiti, Helena M Verkooijen, Georges Vlastos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 16, 2014
Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutationsMaria Caiata-Zufferey, Olivia Pagani, Viviane Cina, et al.
Pageof 6